Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 116 B, Issue 1, 2003, Pages 51-54

  Chong, Siow Ann ^a   Tan, Ene Choo ^b   Tan, Chay Hoon ^c   Mythily, ^a   Chan, Yiong Huak ^d  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b DEFENCE SCIENCE AND TECHNOLOGY AGENCY   (Singapore)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^d MINISTRY OF HEALTH   (Singapore)

Author keywords

Dopamine receptors; Genotype; Polymorphism; Schizophrenia; Tardive dyskinesia

Indexed keywords

BENZODIAZEPINE; CHLORPROMAZINE; DIAZEPAM; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; SERINE;

ADULT; ARTICLE; CHINESE; DNA POLYMORPHISM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0041825283     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10004     Document Type: Article

References (29)

1. American Psychiatric Association. 1997. Practice guidelines for the treatment of patients with schizophrenia. Washington: American Psychiatric Press.
2. Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA, Potkin SG, Macciardi F, Kennedy JL. 1999. Association of the MscI Polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia. Neuropsychopharmacology 21:17-27.
3. Casey DE, Gerlach J, Bjorndal N. 1982. Levodopa and receptor sensitivity modification in tardive dyskinesia. J Psychopharmacol 78:89-92.
4. Chen CH, Liu MY, Wei FC, Koong FJ, Hwa HG, Hsiao KJ. 1997b. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 74:40-43.
5. Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff P. 1998. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. Am J Med Genet 81:318-322.
6. Egan MF, Apud J, Wyatt RJ. 1997. Treatment of tardive dyskinesia. Schizophr Bull 23:583-609.
7. Gaitonde EJ, Morris A, Sivagnanasundaram S, McKenna PJ, Hunt DM, Mollon JD. 1996. Assessment of association of D3 dopamine receptor MscI polymorphism with schizophrenia: analysis of symptom ratings, family history, age at onset, and movement disorders. Am J Med Genet 67:455-458.
8. Garcia-Barcelo MM, Lam LCW, Ungvari GS, Lam VKL, Tang WK. 2001. Dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. J Neural Transm 108:671-677.
9. Grandy DK, Zhang Y, Civelli O. 1993. PCR detection of the TaqARFLP at the DRD2 locus. Hum Mol Genet 2:2197.
10. Guy W. 1976. Assessment manual for psychopharmacology. 76-338. Washington: US Dept. of Health, Education, and Welfare, ECDEU. p 534-537.
11. Hori H, Ohmori O, Shinkai T, Kojima H, Nakamura J. 2001. Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia. Am J Med Genet 105:774-778.
12. Inada T, Dobashi I, Sugita T, Inagaki A, Kitao Y, Matsuda G, Kato S, Takano T, Yagi G, Asai M. 1997. Search for a susceptibility locus to tardive dyskinesia. Human Psychopharmacology 12:35-39.
13. Joober R, Benkelfat C, Brisebois K, Toulouse A, Turecki G, Lal S, Bloom D, Labelle A, Lalonde P, Fortin D, Alda M, Palmour R, Rouleau GA. 1999. T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability. J Psychiatry Neurosci 24:141-146.
14. Kane JM, Aguglia E, Altamura AC, Gutierrez JLA, Brunello N, Fleischhacker WW, Gaebel W, Gerlach J, Guelfi JD, Kissling W, Lapierre YD, Lindstrom E, Mendlewicz J, Racagni G, Carulla LS, Schooler NR. 1998. Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol 8:55-66.
15. Kane JN, Woerner M, Lieberman J. 1985. Tardive dyskinesia: prevalence, incidence and risk factors. In: Casey DE, Chase TN, Christensen AV, et al. Dyskinesia - Research and Treatment. Berlin: Springer-Verlag. p 72-78.
16. Liao DL, Yeh YC, Chen HM, Chen H, Hong CJ, Tsai SJ. 2001. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients. Neuropsychobiology 44:95-98.
17. Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonkar VL, Thelma BK. 1999. Association study of schizophrenia among Indian families. Am J Med Genet 88:298-300.
18. Rietschel M, Krauss H, Muller DJ, Schulze TG, Knapp M, Marwinski K, Maroldt AO, Paus S, Grunhage F, Propping P, Maier W, Held T, Nothen MM. 2000. Dopamine D3 receptor variant and tardive dyskinesia. Eur Arch Psychiatry Clin Neurosci 250:31-35.
19. Schooler NR, Kane JM. 1982. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486-487.
20. Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, Dorevitch A, Yakir A, Lerner A, Shelevoy A, Lerer B. 1999. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 4:247-253.
21. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW. 1996. Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Hum Genet 97:714-719.
22. Simpson GM, Angus JW. 1970. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11-19.
23. Smith JM, Kucharski LT, Oswald WT, Waterman LJ. 1979. Tardive dyskinesia: effects of age, sex and criterion level of symptomatology on prevalence estimates. Psychopharmacol Bull 15:69-71.
24. Steen VM, Lovlie R, MacEwan T, McCreadie RG. 1997. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry 2:139-145.
25. Tanaka T, Igarashi S, Onodera O, Tanaka H, Fukushima N, Takahashi M, Kameda K, Tsuji S, Ihda S. 1996. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia. Am J Med Genet 67:208-211.
26. Waddington JL, Youssef HA. 1988. The expression of schizophrenia, affective disorder, and vulnerability to tardive dyskinesia in an extensive pedigree. Br J Psychiatry 153:376-381.
27. Weinhold P, Wegner JT, Kane JM. 1981. Familial occurrence of tardive dyskinesia. J Clin Psychiatry 42:165-166.
28. Yang L, Weise C, Lannfelt L, Sokoloff P, Xu CT, Zeng Z, Schwartz C, Lui X, Mo HW. 1993. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene. Am J Med Genet 48:83-86.
29. Youssef H, Lyster G, Youssef F. 1989. Familial psychosis and vulnerability to tardive dyskinesia. Int Clin Psychopharmacol 4:323-328.